| RS2467325671 |
TMEM163
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2467329431 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS2467332466 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467332716 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS2467333098 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467333753 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467333810 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467344481 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS2467345309 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467349956 |
SNRNP200
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2467352114 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS2467352953 |
ST3GAL5
|
Health Risk |
Pathogenic |
GM3 synthase deficiency, GM3 synthase deficiency |
| RS2467354598 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS2467357949 |
BCL11A
|
Health Risk |
Pathogenic |
— |
| RS2467360189 |
PDE6B
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2467370162 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
NRXN1-related disorder, NRXN1-related disorder |
| RS2467370218 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Joubert syndrome with renal defect |
| RS2467370270 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis 1 |
| RS2467370400 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467374878 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis 1, Nephronophthisis 1 |
| RS2467374890 |
NPHP1
|
Health Risk |
Pathogenic |
Joubert syndrome with renal defect, Joubert syndrome with renal defect |
| RS2467395269 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467403268 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467403726 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis 1, Nephronophthisis 1 |
| RS2467405206 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis 1, Nephronophthisis 1 |
| RS2467405409 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467425985 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia complementation group L |
| RS2467426348 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2467426571 |
LRP1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467426584 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2467434544 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467441966 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467442575 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467473532 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467473596 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467484485 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2467484660 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2467490891 |
LCT
|
Health Risk |
Likely pathogenic |
— |
| RS2467491761 |
ANTXR1
|
Health Risk |
Likely pathogenic |
GAPO syndrome, GAPO syndrome |
| RS2467501358 |
LCT
|
Health Risk |
Pathogenic |
— |
| RS2467507426 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467507433 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467508032 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467508347 |
PEX13
|
Health Risk |
Pathogenic |
PEX13-related disorder, Peroxisome biogenesis disorder |
| RS2467508404 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467508461 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467508700 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467520088 |
GLI2
|
Health Risk |
Likely pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS2467524698 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2467527058 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467527251 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467527282 |
PEX13
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS2467529750 |
RANBP2
|
Health Risk |
Likely pathogenic |
Familial acute necrotizing encephalopathy, Familial acute necrotizing encephalopathy |
| RS2467548016 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2467555675 |
POLR1B
|
Health Risk |
Likely pathogenic |
Treacher Collins syndrome 4, Treacher Collins syndrome 4 |
| RS2467598236 |
NPHP1
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467599107 |
NPHP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome with renal defect, Nephronophthisis |
| RS2467599617 |
NPHP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome with renal defect, Nephronophthisis |
| RS2467608578 |
TBCK
|
Health Risk |
Likely pathogenic |
TBCK-related disorder, TBCK-related disorder |
| RS2467621338 |
NPHP1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2467623019 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467633371 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467634622 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467634733 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467635159 |
TET3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467635315 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467640486 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467640491 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467640539 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467640652 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467641602 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467641656 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467644775 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467644943 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467645024 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467645025 |
MMADHC
|
Health Risk |
Likely pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS2467645031 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467645084 |
MMADHC
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467647793 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467648001 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2467651823 |
TET3
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467653249 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Squamous cell lung carcinoma |
| RS2467655463 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia complementation group L |
| RS2467657005 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467657092 |
TET3
|
Health Risk |
Pathogenic |
— |
| RS2467657340 |
FANCL
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group L |
| RS2467657643 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia complementation group L |
| RS2467684945 |
TET3
|
Health Risk |
Likely pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467686025 |
TET3
|
Health Risk |
Pathogenic |
Beck-Fahrner syndrome, Beck-Fahrner syndrome |
| RS2467686698 |
GLI2
|
Health Risk |
Pathogenic |
GLI2-related disorder, GLI2-related disorder |
| RS2467699176 |
GLI2
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS2467727114 |
GLI2
|
Health Risk |
Likely pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467737048 |
EXOC6B
|
Health Risk |
Pathogenic |
— |
| RS2467749474 |
GLI2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2467766888 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467768078 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS2467768738 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467770120 |
GLI2
|
Health Risk |
Pathogenic |
Holoprosencephaly 9, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2467775195 |
GLI2
|
Health Risk |
Likely pathogenic |
Holoprosencephaly 9, Holoprosencephaly 9 |
| RS2467776444 |
GLI2
|
Health Risk |
Likely pathogenic |
GLI2-related disorder, GLI2-related disorder |